Table 1.
Characteristics of 68 pre-treatment tumor specimens derived from 41 patients receiving anti-PD-1 therapy.
Characteristic | No. of Patients (N=41) |
---|---|
Patient response to treatment | |
Complete | 2 |
Partial | 8 |
Stable disease ≥6 months | 2 |
No response | 29 |
Patient diagnosis | |
Melanoma | 16 |
Non-small cell lung cancera | 12 |
Kidney cancer | 6 |
Colorectal cancer | 5 |
Castration-resistant prostate cancer | 2 |
No. tumor specimens analyzed per patient | |
1 | 25 |
2 | 9 |
3 | 5 |
4 | 0 |
5 | 2 |
No. of Specimens (N=68) | |
Primary vs. metastatic tumor | |
Primary | 29 |
Metastasis | 39 |
Anatomic location | |
lymph node (metastasis) | 17 |
lung (primary or metastasis) | 15 |
other | 36 |
Twelve cases include 9 adenocarcinomas and 3 squamous cell carcinomas of the lung.